Skip to content
Sign in

VFVA · BATS · ETF

Vanguard U.S. Value Factor ETF (VFVA) Price, Holdings & Fees

$397.06−0.60%−$2.41End-of-day price as of Oct 9, 2026

Vanguard U.S. Value Factor ETF (VFVA) closed at $397.06 on Oct 9, 2026, down 0.60% from the previous close of $399.47.

Share price, past year

1Y +6.13%

52-week range $351.22 – $408.20. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$397.06
Sep 30, 2026$392.09
Aug 31, 2026$396.88
Jul 31, 2026$374.84
Jun 30, 2026$382.84
May 29, 2026$397.81
Apr 30, 2026$390.77
Mar 31, 2026$383.36
Feb 27, 2026$392.25
Jan 30, 2026$354.38
Dec 31, 2025$363.64
Nov 28, 2025$384.98
Oct 31, 2025$380.58

Key statistics

Expense ratio
0.13%
as of Nov 30, 2025
Net assets
$825.9M
as of May 31, 2026
Holdings
653
as of May 31, 2026
52-week range
$351.22 – $408.20

Vanguard U.S. Value Factor ETF's expense ratio is 0.13%: $13.00 a year on $10,000 invested.

Holdings

Vanguard U.S. Value Factor ETF held 653 investments worth $825.86M as of May 31, 2026. Its largest holding was CVS Health Corp, at 0.95% of the fund.

Vanguard U.S. Value Factor ETF largest holdings by share of net assets
#Holding% of fundValue
1CVS Health Corp0.95%$7.84M
2EOG Resources Inc0.89%$7.31M
3General Motors Co0.86%$7.07M
4Bristol-Myers Squibb Co0.85%$7.03M
5Verizon Communications Inc0.85%$7.01M
6Cigna Group/The0.85%$7.00M
7AT&T Inc0.78%$6.41M
8FedEx Corp0.77%$6.37M
9Elevance Health Inc0.76%$6.25M
10Accenture PLC0.72%$5.94M
11Pfizer Inc0.71%$5.90M
12US Bancorp0.68%$5.63M
13Truist Financial Corp0.68%$5.58M
14Fiserv Inc0.66%$5.46M
15Merck & Co Inc0.65%$5.39M
16QUALCOMM Inc0.63%$5.19M
17Altria Group Inc0.61%$5.06M
18Booking Holdings Inc0.60%$4.99M
19Salesforce Inc0.60%$4.95M
20Marathon Petroleum Corp0.59%$4.89M
21UnitedHealth Group Inc0.58%$4.82M
22Comcast Corp0.58%$4.77M
23Chubb Ltd0.57%$4.70M
24Adobe Inc0.55%$4.51M
25BorgWarner Inc0.53%$4.38M

Top 25 of 653 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Vanguard U.S. Value Factor ETF holdings by asset type
Asset type% of fund
Stocks99.66%
Cash and short-term investments0.17%
Derivatives0.01%
Vanguard U.S. Value Factor ETF holdings by country, largest 1
Country% of fund
United States99.83%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Vanguard U.S. Value Factor ETF's total return was +3.99%, as reported to the SEC.

Vanguard U.S. Value Factor ETF monthly total returns
MonthTotal return
May 31, 2026+1.27%
Apr 30, 2026+7.08%
Mar 31, 2026−4.11%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Vanguard U.S. Value Factor ETF
Ticker
VFVA
Exchange
BATS
Fund type
ETF
Trust
VANGUARD WELLINGTON FUND
SEC series ID
S000061305
SEC CIK
0000105563
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by VANGUARD WELLINGTON FUND, the trust behind Vanguard U.S. Value Factor ETF, and cover all of its funds.

Frequently asked questions

What is VFVA's price?

Vanguard U.S. Value Factor ETF (VFVA) closed at $397.06 on Oct 9, 2026, down 0.60% from the previous close of $399.47.

What is VFVA's expense ratio?

Vanguard U.S. Value Factor ETF's expense ratio is 0.13%: $13.00 a year on $10,000 invested.

What does VFVA hold?

Vanguard U.S. Value Factor ETF held 653 investments worth $825.86M as of May 31, 2026. Its largest holding was CVS Health Corp, at 0.95% of the fund. Its five largest holdings were CVS Health Corp, EOG Resources Inc, General Motors Co, Bristol-Myers Squibb Co, Verizon Communications Inc.

How has VFVA performed?

Over the 3 months to May 31, 2026, Vanguard U.S. Value Factor ETF's total return was +3.99%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 29, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Nov 30, 2025. Prices are generated sample data for development. Data sources and disclosures